Prognostic Factors in Lobar World Health Organization Grade II Astrocytomas

World Neurosurgery
Mueez WaqarMichael D Jenkinson

Abstract

World Health Organization grade II astrocytomas (AII) are the commonest low-grade glioma subset, but their prognostic factors are subject to debate. This institutional study aimed to identify prognostic factors in lobar AII. Retrospective review of newly diagnosed, lobar AII between 2006 and 2012. Patient demographics, imaging, and treatment data were obtained. Isocitrate dehydrogenase-1 (IDH1) status was assessed via immunohistochemistry. Multivariate analysis was performed with Cox regression to identify prognostic factors for overall survival (OS) and progression-free survival (PFS). A total of 92 adult patients were identified with a median age of 42 years (range 20-73 years) and median follow-up period of 45 months (range, 7-98 months). Seizures were the commonest mode of presentation (75%). IDH1 immunopositivity was seen in 46 of 83 patients (55%). Radiology diagnosis agreed with histology in 76% of cases, and 28% of tumors had documented evidence of some degree of contrast enhancement. Surgical management was either resection (51%) or biopsy (49%) and postoperative radiotherapy was used in patients with unfavorable prognostic features. The median OS and PFS were 85 months (range 2-98 months) and 36 months (95% confidence...Continue Reading

References

Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Francesco PignattiUNKNOWN European Organization for Research and Treatment of Cancer Radiotherapy Cooperative Group
Mar 8, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Justin S SmithMitchel S Berger
Apr 14, 2009·Journal of Neurosurgery·Kaisorn L ChaichanaAlfredo Quiñones-Hinojosa
Jul 29, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marc SansonJean-Yves Delattre
Oct 13, 2009·Biochemical and Biophysical Research Communications·Yukinari KatoDarell D Bigner
Aug 20, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·R SoffiettiW Wick
Oct 30, 2010·Annals of Neurology·Johan PalludLaurent Capelle
Nov 16, 2010·The American Journal of Pathology·Young-Ho KimHiroko Ohgaki
Sep 6, 2011·Clinical Neurology and Neurosurgery·Tae-Young JungWoo-Youl Jang
Mar 20, 2012·Clinical Neurology and Neurosurgery·Krzysztof MajchrzakPiotr Ładziński
Aug 28, 2012·Oncology Reports·Jae Kyung MyungSung-Hye Park
Oct 27, 2012·JAMA : the Journal of the American Medical Association·Asgeir S JakolaOle Solheim
Jan 5, 2013·Arquivos de neuro-psiquiatria·André de Macedo BiancoSuely K Nagahashi Marie
Oct 3, 2013·Acta neurochirurgica·Johan PalludEmmanuel Mandonnet
Jan 15, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roshan S PrabhuMinesh P Mehta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.